Literature DB >> 11916551

Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in children.

L C M Kremer1, B A J Bastiaansen, M Offringa, J Lam, J P van Straalen, R J de Winter, P A Voûte.   

Abstract

Early detection of damage to cardiac myocytes after cardiotoxic chemotherapy in paediatric patients may allow timely preventive measures to be taken. We investigated the diagnostic value of cardiac troponin T (cTnT) after the administration of cardiotoxic chemotherapy. In 38 children, cTnT levels were measured at three time points during the first 24 h after 58 cardiotoxic chemotherapy cycles (163 samples). An abnormal cTnT level, defined as a cTnT>0.010 ng/ml, was measured in only six samples from 3 patients. After completion of chemotherapy, 7 out of the 38 patients had left ventricular dysfunction (LV dysfunction). Only 1 of these 7 patients had an elevated cTnT level. 2 other patients with elevated cTnT levels did not develop LV dysfunction until 2 and 7 months after the cTnT measurement. Our data show that the measurement of cTnT within 24 h after administration of chemotherapy does not have a high sensitivity for the identification of patients with subsequent subclinical cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916551     DOI: 10.1016/s0959-8049(01)00431-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  Alternative Biomarkers for Combined Biology.

Authors:  Yong-Hyun Kim; Jennifer Kirsop; Wai Hong Wilson Tang
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

Review 2.  Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.

Authors:  Eric S Christenson; Theodore James; Vineet Agrawal; Ben H Park
Journal:  Clin Biochem       Date:  2014-11-07       Impact factor: 3.281

3.  Cardiac troponin T in children with acute rheumatic carditis.

Authors:  Osman Ozdemir; Deniz Oguz; Emel Atmaca; Cihat Sanli; Ayse Yildirim; Rana Olgunturk
Journal:  Pediatr Cardiol       Date:  2010-10-19       Impact factor: 1.655

4.  Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.

Authors:  Krithika Srikanthan; Rebecca Klug; Maria Tirona; Ellen Thompson; Haresh Visweshwar; Nitin Puri; Joseph Shapiro; Komal Sodhi
Journal:  J Clin Exp Cardiolog       Date:  2017-03-22

5.  Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.

Authors:  Fotiní Dodos; Teresa Halbsguth; Erland Erdmann; Uta C Hoppe
Journal:  Clin Res Cardiol       Date:  2008-01-14       Impact factor: 5.460

6.  Plasma high sensitivity troponin T levels in adult survivors of childhood leukaemias: determinants and associations with cardiac function.

Authors:  Yiu-fai Cheung; Wei Yu; Daniel Ka-leung Cheuk; Frankie Wai-tsoi Cheng; Janet Yee-kwan Yang; Jeffrey Ping-wa Yau; Karin Ka-huen Ho; Chi-kong Li; Rever Chak-ho Li; Hui-Leung Yuen; Alvin Siu-cheung Ling; Vivian Wing-yi Li; Wai-keung Wong; Kwong-cheong Tsang; Godfrey Chi-fung Chan
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 7.  The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy.

Authors:  Christine Henri; Therese Heinonen; Jean-Claude Tardif
Journal:  Biomark Cancer       Date:  2016-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.